Harbor:Empiric antibiotics: Difference between revisions
Gtchakalian (talk | contribs) |
Gtchakalian (talk | contribs) |
||
| Line 6: | Line 6: | ||
*[[File:Harbor-UCLA_Medical_Center_Empiric_Antibiotic_Recommendations_for_Inpatient_Adult_2022.pdf|Harbor-UCLA Medical Center Empiric Antibiotic Recommendations for Inpatient Adult 2022]] | *[[File:Harbor-UCLA_Medical_Center_Empiric_Antibiotic_Recommendations_for_Inpatient_Adult_2022.pdf|Harbor-UCLA Medical Center Empiric Antibiotic Recommendations for Inpatient Adult 2022]] | ||
*[[File:Harbor-UCLA_Medical_Center_Empiric_Antibiotic_Recommendations_for_Outpatient_Adult_2022.pdf|Harbor-UCLA Medical Center Empiric Antibiotic Recommendations for Outpatient Adult 2022]] | *[[File:Harbor-UCLA_Medical_Center_Empiric_Antibiotic_Recommendations_for_Outpatient_Adult_2022.pdf|Harbor-UCLA Medical Center Empiric Antibiotic Recommendations for Outpatient Adult 2022]] | ||
**SKIN & SOFT TISSUE INFECTIONS (SSTI) | |||
***Cellulitis (no purulence) (x 5-7 days) | |||
****Dual antibiotic treatment is not indicated. Cephalexin 500mg PO QID OR Clindamycin 450mg PO TID OR | |||
TMP-SMX* DS 1-2 tabs PO BID (2 tabs if >100kg) | |||
==See Also== | ==See Also== | ||
Revision as of 23:08, 7 July 2022
This page is for antibiotics specific to the Harbor-UCLA Medical Center; see Antibiotics by diagnosis for for national guidelines.
Harbor:Antibiotics by diagnosis
Harbor Empiric Guidelines
- File:Harbor-UCLA Medical Center Empiric Antibiotic Recommendations for Inpatient Adult 2022.pdf
- File:Harbor-UCLA Medical Center Empiric Antibiotic Recommendations for Outpatient Adult 2022.pdf
- SKIN & SOFT TISSUE INFECTIONS (SSTI)
- Cellulitis (no purulence) (x 5-7 days)
- Dual antibiotic treatment is not indicated. Cephalexin 500mg PO QID OR Clindamycin 450mg PO TID OR
- Cellulitis (no purulence) (x 5-7 days)
- SKIN & SOFT TISSUE INFECTIONS (SSTI)
TMP-SMX* DS 1-2 tabs PO BID (2 tabs if >100kg)
See Also